Abstract:Background: CYP2D6 testing is increasingly used to guide drug therapy and thus, reliable methods are needed to test this complex and polymorphic gene locus. A particular challenge arises from the detection and interpretation of structural variants (SVs) including gene deletions, duplications, and hybrids with the CYP2D7 pseudogene. This study validated the Absolute Q™ platform for digital PCR-based CYP2D6 copy number variation (CNV) determination by comparing results to those obtained with a previously established method using the QX200 platform. In addition, protocols for streamlining CYP2D6 CNV testing were established and validated including the "One-pot" single-step restriction enzyme digestion and a multiplex assay simultaneously targeting the CYP2D6 5'UTR, intron 6, and exon 9 regions. Methods: Genomic DNA (gDNA) samples from Coriell (n = 13) and from blood, saliva, and liver tissue (n = 17) representing 0-6 copies were tested on the Absolute Q and QX200 platforms. Custom TaqMan™ copy number (CN) assays targeting CYP2D6 the 5'UTR, intron 6, and exon 9 regions and a reference gene assay (TERT or RNaseP) were combined for multiplexing by optical channel. In addition, two digestion methods (One-pot digestion and traditional) were assessed. Inconclusive CN values on the Absolute Q were resolved using an alternate reference gene and/or diluting gDNA. Results: Overall, results between the two platforms and digestions methods were consistent. The "One-pot" digestion method and optically multiplexing up to three CYP2D6 regions yielded consistent result across DNA sample types and diverse SVs, reliably detecting up to 6 gene copies. Rare variation in reference genes were found to interfere with results and interpretation, which were resolved by using a different reference. Conclusion: The Absolute Q produced accurate and reliable CYP2D6 copy number results allowing for a streamlined and economical protocol using One-pot digestion and multiplexing three target regions. Protocols are currently being expanded to other pharmacogenes presenting with SVs/CNVs.

DCD-chip designed for the digital and ultraprecise quantification of copy number variation

Recent Advance in Digital PCR

Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling

CYP2D6 copy number determination using digital PCR

High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number

DL-CNV: A Deep Learning Method for Identifying Copy Number Variations Based on Next Generation Target Sequencing

Single-Cell-Based Platform for Copy Number Variation Profiling Through Digital Counting of Amplified Genomic DNA Fragments

Comparison of real-time quantitative PCR and two digital PCR platforms to detect copy number variation in FCGR3B

A Rapid PCR-Free Next-Generation Sequencing Method for the Detection of Copy Number Variations in Prenatal Samples

A Novel Multiplex Fluorescent Competitive PCR for Copy Number Variation Detection.

An integrated droplet digital PCR gene chip for absolute quantification of nucleic acid

PEcnv: accurate and efficient detection of copy number variations of various lengths

A Remark on Copy Number Variation Detection Methods

CNV-P: a machine-learning framework for predicting high confident copy number variations

Detection of somatic copy number deletion of the CDKN2A gene by quantitative multiplex PCR for clinical practice

Accurate quantification of DNA using on-site PCR (osPCR) by characterizing DNA amplification at single-molecule resolution

A 3D Scalable Chamber-Array Chip for Digital LAMP.

SeqCNV: a Novel Method for Identification of Copy Number Variations in Targeted Next-Generation Sequencing Data

Comparative Study of Three PCR-Based Copy Number Variant Approaches , CFMSA , M-PCR , and MLPA , in 22 Q 11 . 2 Deletion Syndrome

Copy Number Variation Detection In Whole-Genome Sequencing Data Using The Bayesian Information Criterion

A Double-Deck Self-Digitization Microfluidic Chip for Digital PCR